DE68913054D1 - Verwendung von 4-substituierten-Imidazol-Derivaten in der perioperativen Medikation. - Google Patents

Verwendung von 4-substituierten-Imidazol-Derivaten in der perioperativen Medikation.

Info

Publication number
DE68913054D1
DE68913054D1 DE89301866T DE68913054T DE68913054D1 DE 68913054 D1 DE68913054 D1 DE 68913054D1 DE 89301866 T DE89301866 T DE 89301866T DE 68913054 T DE68913054 T DE 68913054T DE 68913054 D1 DE68913054 D1 DE 68913054D1
Authority
DE
Germany
Prior art keywords
perioperative
medication
substituted
imidazole derivatives
imidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89301866T
Other languages
English (en)
Other versions
DE68913054T2 (de
Inventor
Mervyn Maze
Mika Scheinin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Oy filed Critical Orion Yhtyma Oy
Publication of DE68913054D1 publication Critical patent/DE68913054D1/de
Application granted granted Critical
Publication of DE68913054T2 publication Critical patent/DE68913054T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE68913054T 1988-02-29 1989-02-24 Verwendung von 4-substituierten-Imidazol-Derivaten in der perioperativen Medikation. Expired - Fee Related DE68913054T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8804683A GB2215206B (en) 1988-02-29 1988-02-29 4-substituted imidazole derivatives useful in perioperative care

Publications (2)

Publication Number Publication Date
DE68913054D1 true DE68913054D1 (de) 1994-03-24
DE68913054T2 DE68913054T2 (de) 1994-07-07

Family

ID=10632543

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68913054T Expired - Fee Related DE68913054T2 (de) 1988-02-29 1989-02-24 Verwendung von 4-substituierten-Imidazol-Derivaten in der perioperativen Medikation.

Country Status (13)

Country Link
EP (1) EP0331374B1 (de)
JP (1) JP2856410B2 (de)
KR (1) KR0136790B1 (de)
AT (1) ATE101514T1 (de)
AU (1) AU611262B2 (de)
CA (1) CA1338556C (de)
DE (1) DE68913054T2 (de)
DK (1) DK175282B1 (de)
GB (1) GB2215206B (de)
HU (1) HU202751B (de)
IE (1) IE60538B1 (de)
NZ (1) NZ228125A (de)
ZA (1) ZA891493B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
GB9111732D0 (en) * 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
GB2281206A (en) * 1993-08-25 1995-03-01 Orion Yhtymae Oy Use of dexmedetomidine
WO1997024354A1 (fr) * 1995-12-28 1997-07-10 The Procter & Gamble Company 6-r-1,3,4-thiadiazine-2-amines substitues, leur utilisation en qualite d'agents anesthesiques, cardio-vasculaires et hypometaboliques, et composition pharmaceutique les contenant
WO1997024353A1 (fr) * 1995-12-28 1997-07-10 The Procter & Gamble Company 6-h-1,3,4-thiadiazine-2-amines substitues, leur utilisation en qualite d'agents anesthesiques, cardio-vasculaires et hypometaboliques, et composition pharmaceutique les contenant
ES2172606T3 (es) * 1995-12-28 2002-10-01 N T Predpr Ligand Obschestvo S 6-h-1,3,4-tiadiazin-2-aminas, su uso como agentes anestesicos, cardiovasculares e hipometabolicos, y una composicion farmaceutica que las contiene.
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
JP2009524616A (ja) * 2006-01-27 2009-07-02 エフ.ホフマン−ラ ロシュ アーゲー Cns疾患のための4−イミダゾール誘導体の使用
AU2007312390B2 (en) 2006-10-19 2013-03-28 F. Hoffmann-La Roche Ag Aminomethyl-4-imidazoles
JP5064511B2 (ja) 2006-11-02 2012-10-31 エフ.ホフマン−ラ ロシュ アーゲー 痕跡アミン関連受容体調節剤としての置換2−イミダゾール
KR101134226B1 (ko) 2006-11-16 2012-04-10 에프. 호프만-라 로슈 아게 치환된 4-이미다졸
WO2008071574A1 (en) 2006-12-13 2008-06-19 F. Hoffmann-La Roche Ag Novel 2 -imidazoles as ligands for trace amine associated receptors (taar)
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
JP5248528B2 (ja) 2007-02-02 2013-07-31 エフ.ホフマン−ラ ロシュ アーゲー Cns疾患用のtaar1リガンドとしての新規2−アミノオキサゾリン
CA2676944C (en) 2007-02-15 2016-01-19 F. Hoffmann-La Roche Ag 2-aminooxazolines as taar1 ligands
EP2173720A2 (de) 2007-07-02 2010-04-14 F. Hoffmann-Roche AG 2-imidazoline mit guter affinität zu trace-amine-associated-rezeptoren (taars)
BRPI0812833A2 (pt) 2007-07-03 2014-12-09 Hoffmann La Roche 4-imidazolinas e seu uso como antidepressivos
KR101133862B1 (ko) 2007-07-27 2012-04-06 에프. 호프만-라 로슈 아게 Taar 리간드로서의 2-아제티딘메테인아민 및 2-피롤리딘메테인아민
AU2008285795A1 (en) 2007-08-03 2009-02-12 F. Hoffmann-La Roche Ag Pyridinecarboxamide and benzamide derivatives as TAAR1 ligands
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
AU2010213580A1 (en) * 2009-02-13 2011-09-08 Allergan, Inc. Pharmaceutical compositions comprising (3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
WO2013078151A1 (en) 2011-11-21 2013-05-30 Allergan, Inc. Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole derivatives for treating retinal diseases
EP3054930B1 (de) 2013-10-07 2020-12-02 Teikoku Pharma USA, Inc. Verfahren und zusammensetzungen zur transdermalen verabreichung einer nicht-sedierenden menge an descmedetomidin
CN105764494A (zh) 2013-10-07 2016-07-13 帝国制药美国公司 右旋美托咪啶经皮递送装置及其使用方法
WO2015054059A2 (en) 2013-10-07 2015-04-16 Teikoku Pharma Usa, Inc. Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
SG11201807516UA (en) 2016-03-17 2018-09-27 Hoffmann La Roche 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar
EP3532038A4 (de) * 2016-10-31 2020-06-03 Teikoku Pharma USA, Inc. Verfahren zur verwaltung von schmerzen mithilfe von vorrichtungen zur transdermalen verabreichung von dexmedetomidin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202660A (en) 1961-10-09 1965-08-24 Boehringer Sohn Ingelheim Process for the preparation of 3-arylamino-1, 3-diazacycloalkenes
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative

Also Published As

Publication number Publication date
GB2215206B (en) 1991-07-03
ATE101514T1 (de) 1994-03-15
GB8804683D0 (en) 1988-03-30
JP2856410B2 (ja) 1999-02-10
KR890012647A (ko) 1989-09-18
EP0331374B1 (de) 1994-02-16
GB2215206A (en) 1989-09-20
AU3027289A (en) 1989-08-31
EP0331374A3 (en) 1990-10-10
CA1338556C (en) 1996-08-27
AU611262B2 (en) 1991-06-06
IE890639L (en) 1989-08-29
HUT51139A (en) 1990-04-28
DK46489A (da) 1989-08-30
EP0331374A2 (de) 1989-09-06
DK175282B1 (da) 2004-08-09
HU202751B (en) 1991-04-29
JPH01294623A (ja) 1989-11-28
KR0136790B1 (ko) 1998-04-25
ZA891493B (en) 1989-11-29
DE68913054T2 (de) 1994-07-07
IE60538B1 (en) 1994-07-27
DK46489D0 (da) 1989-02-02
NZ228125A (en) 1996-12-20

Similar Documents

Publication Publication Date Title
ATE101514T1 (de) Verwendung von 4-substituierten-imidazolderivaten in der perioperativen medikation.
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
DK0726899T3 (da) Nye pyrazincarboxamidderivater, deres fremstilling og deres anvendelse i lægemidler
FI865269A (fi) Kvaevehaltiga heterocykliska foereningar.
DE69230013D1 (de) Fibrinogen-Rezeptor-Antagonisten
DE69224552D1 (de) Fibrinogen-Rezeptor-Antagonisten
DE3780618D1 (de) Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
DE3774858D1 (de) Derivate von n-(2-alkyl-3-mercaptoglutaryl)-alpha-aminosaeuren und deren verwendung als collagenase-inhibitoren.
DE59407431D1 (de) Verwendung aromatischer Carbonsäurederivate zur Herstellung von pharmazeutischen Präparaten
MY102323A (en) New ribofuranuronic acid derivatives
ATE102191T1 (de) Substituierte 4-(1h-imidazol-1-yl>benzamide als antiarrhythmische mittel.
ATE59294T1 (de) Stabilisierte arzneimittel.
ES2075272T5 (es) Composiciones dermatologicas conteniendo acido cis-urocanico.
ATE116854T1 (de) Verwendung von buspiron in schlaf-apnoe.
ATE74138T1 (de) Heptanoyl-glu-asp-ala-amino-saeureimmunstimulanten.
DE59508900D1 (de) Verwendung von Dibrom-thiophen-carbonsäure-Derivaten als Mikrobizide
DE69130266D1 (de) Optisch wirksame Alkylendioxybenzolderivate und ihre Verwendung als Arzneimittel
ATE86982T1 (de) Benzimidazol-derivate.
DE68900657D1 (de) Verwendung der 4-((2-oxo-3-bornyliden)methyl)benzolsulfonsaeure oder deren salze zur erhaltung der mechanischen haareigenschaften gegenueber atmosphaerischen einfluessen.
DE68918651D1 (de) Verwendung von Imidazopyrazolderivaten als analgesische und antiinflammatorische Mittel.
ATE66921T1 (de) Verwendung von triazolylderivate zur bekaempfung von pilzen.
DE3874361D1 (de) Als analgetika verwendbare 1-((4-morpholinyl)alkyl)-1h-indole und deren herstellung.
ATE69810T1 (de) Derivate von n-(2-alkyl-3-mercaptoglutaryl)-alpha-aminosaeure und deren verwendung als collagenaseinhibitoren.
SU1466219A1 (ru) Производные 1-(4-тиоцианатофенил)-5-(2-фурил-Δ-пиразолина, проявляющие анальгетическую активность
FR2628322B1 (fr) Nouvelles utilisations therapeutiques de l'acide 4-(3-phosphono-2-propenyl)-piperazine-2-carboxylique

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee